ASH Scotland welcomes tighter regulations on smoking and e-cigarettes.

Sep.28.2022
ASH Scotland welcomes tighter regulations on smoking and e-cigarettes.
ASH Scotland welcomes tighter regulations on advertising and promoting e-cigarette products to protect Scottish youth and non-smokers.

ASH Scotland welcomes the tightening of regulations on advertising and promoting e-cigarette products as a step towards protecting the health of Scottish children, young people, and non-smoking adults.


Earlier this year, the Scottish government conducted a consultation seeking views on proposed regulations aimed at balancing the protection of non-smokers and providing information to smokers.


Sheila Duffy, the CEO of ASH Scotland, expressed her welcome for the release of the report, stating a hope for action to be taken towards implementing the advertising and promotional restrictions that were passed by the Scottish Parliament and became law in 2016. Reports of significantly increased usage of disposable e-cigarettes among children and young people make these measures urgently needed.


Promoting new products is a clear way for the tobacco industry to reach potential consumers for future generations. Seeking opinions on measures to curb advertising and promotion of recreational novels is crucial in protecting young people from being tempted to experiment.


Young people who try electronic cigarettes are at a much higher risk of developing nicotine addiction and later transitioning to tobacco use. We all hope to spare our children this prospect, as smoking is a direct cause of 16% of all deaths in Scotland.


Duffy added, "The World Health Organization expressed concern that children who use these products may be three times more likely to use tobacco products in the future. This concern was also supported by a global systematic evidence review published by Australians earlier this year.


The long-term health risks of e-cigarettes are largely unknown. However, it is known that most e-cigarettes contain nicotine, which is highly addictive, and that the e-liquid may also contain other toxic elements. Lesser harm does not mean harmless.


Most adults have heard of electronic cigarette products, which can be purchased and used if one wishes, but they are not approved smoking cessation products. Rather, they are primarily marketed as commercial entertainment products, with features such as color, flavor, and price intended to attract children and adolescents. The NHS does not offer electronic cigarettes as part of its prescription service. Rather, we encourage anyone looking to quit smoking to seek out local pharmacies or smoking cessation services, which offer person-centered approaches to quitting.


Statement:


The content of this article is compiled from third-party information and is only intended for industry exchange and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the content. The translation of this article is intended for industry communication and research purposes only.


Due to limitations in translation ability, the translated article may not express the original text exactly. Please refer to the original for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macao, Taiwan, and foreign-related expressions and stances.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Malaysia Urged to Act as Teen E-cigarette Use Rises
Malaysia Urged to Act as Teen E-cigarette Use Rises
As youth vaping continues to rise in Malaysia, the Malaysian Thoracic Society and the Lung Foundation are urging the government to immediately enforce the Control of Smoking Products for Public Health Act 2024. Experts warn that many e-cigarettes are designed to resemble toys, candies or USB drives, making them highly appealing to teenagers and potentially acting as a gateway to drug use.
May.20 by 2FIRSTS.ai
Canadian Conservative Party Promises to Relax Nicotine Pouch Sales Channels if Elected
Canadian Conservative Party Promises to Relax Nicotine Pouch Sales Channels if Elected
The Canadian Conservative Party has pledged that if elected, it will lift the regulation restricting nicotine pouches to pharmacy sales, allowing adult consumers to purchase them at convenience stores and gas stations.
Apr.27 by 2FIRSTS.ai
PMI Launches IQOS Pilot in Florida, Advancing Market Layout in the US
PMI Launches IQOS Pilot in Florida, Advancing Market Layout in the US
PMI’s U.S. subsidiary has launched the IQOS pilot program “Be the First” in Florida, further advancing its market layout in the U.S. following the pilot in Texas.
May.06 by 2FIRSTS.ai
PMI speaks out: IQOS is not an e-cigarette, legal to sell in Mexico
PMI speaks out: IQOS is not an e-cigarette, legal to sell in Mexico
Philip Morris International (PMI) defends the legality of IQOS as a heated tobacco device in Mexico.
Apr.18 by 2FIRSTS.ai
Tobacco Growers Discuss Shared Challenges and Opportunities at ITGA Regional Meeting
Tobacco Growers Discuss Shared Challenges and Opportunities at ITGA Regional Meeting
The ITGA Americas meeting gathered growers and stakeholders from key regions to address climate impacts, rising production costs, and shifting global demand. 2Firsts was invited to attend, with Editor-in-Chief Taco Tuinstra reporting on-site.
Jun.04
FDA Embraces AI: Generative System to Be Fully Operational by June's End
FDA Embraces AI: Generative System to Be Fully Operational by June's End
FDA plans to fully integrate a generative AI system across its centers by June 30, 2025. This follows the successful completion of an initial pilot, marking a shift in the agency's approach to regulatory processes. The AI tools are expected to streamline the drug approval process, which typically takes six to ten months, by reducing time spent on repetitive tasks.
May.09 by 2FIRSTS.ai